Composite

Part:BBa_K1650005:Experience

Designed by: Anna Knoerlein   Group: iGEM15_Marburg   (2015-09-18)

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out. This part was characterised from the iGEM Team Marburg 2015 as part of their InterLab Study and Measurement Study. It was named Device 6 in the further characterisation. First, the fluorescence was measured in the stationary phase, diluted to an OD of 0,5. As described on the registry page of the constitutive promoter family we used construct 1 to 3 with decreasing promoter activity. In construct 4+5 we used the same promotor as in construct 1+2, they just expressed RFP instead GFP In most cases, the normalized promoter activity was higher in MG1655 than in DH5alpha.Taken together, we show that the chassis plays an important role for the characterization of a construct. In order to provide a comprehensive characterization/analysis we used both, the commonly used cloning strain DH5alpha as well as the wildtype strain MG1655 for our further studies.

Figure 1: Fluorescence at the stationary phase .
Figure 2: Fluorescence at the stationary phase .
The timelapse measurement of our constructs reveals that fluorescence intensity increases over time. The used fluorescent proteins are not fused to a degradation tag, which may have led to an accumulation of GFP and RFP and hence to an increase of fluorescence intensity. In accordance with the one-point measurements in the plate reader, we observed a variation between the two different chassis. Also the expression levels and the ratios of fluorescence intensities are consistent.
Figure 3: GFP over time .
Figure 4: RFP over time.
The device was also characterisated throught flow cytometry.
Figure 5: Flow cytometry

Applications of BBa_K1650005

User Reviews

UNIQdf2d6a2c774e72fa-partinfo-00000001-QINU UNIQdf2d6a2c774e72fa-partinfo-00000002-QINU